Merck & Co., Inc. (NYSE:MRK)

DNA

UBS Top Stocks to Buy Working for Cancer Cures

Cancer is the leading cause of death globally, and a disease that touches almost every person in our nation one way or another. In a new research report, the Healthcare ...
Read Full Story »
Johnson & Johnson Logo

Johnson & Johnson Earnings Point to New 52-Week High

Johnson & Johnson (NYSE: JNJ) reported first-quarter results before markets opened Tuesday. The health care giant reported quarterly adjusted diluted earnings per share (EPS) of $1.54 on revenue of $18.1 ...
Read Full Story »
buy sell

Gilead Risks Beyond Just Merck: Serious Chart Violation Watch

Gilead Sciences Inc. (NASDAQ: GILD) may have been largely responsible for the drop in biotech stocks after politicians went after its drug costs, but an excessive multiyear performance above and ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Inspired The Bounce

April 9, 2014: Markets opened higher on Wednesday and then got a jolt higher following the afternoon release of the FOMC’s last meeting minutes. The minutes indicated to many investors ...
Read Full Story »
buy sell

Telecoms Liven Up Short Interest in Big Dividend Stocks

The short interest data for the first two weeks of March is out, and the results among the top high-yield safe dividend stocks are mixed. The biggest changes took place ...
Read Full Story »
Pfizer logo

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

With the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Charged the Market Higher

March 25, 2014: Markets opened higher on Tuesday but dipped sharply in the late morning on weakness in consumer discretionary, financial, and biotech stocks. The Dow and the S&P 500 ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Pushed Stocks Lower on Monday

March 24, 2014: Markets opened slightly higher on Monday but soon took a turn south and spent most of the day solidly down. Biotechs, healthcare, discretionary, and tech stocks were ...
Read Full Story »
stock symbol ticker

The 5 Stocks That Sank Markets on Friday

March 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled solidly lower. It took the Dow and the S&P 500 ...
Read Full Story »
biotech

Did Endocyte Just Become Buyout Bait?

Endocyte Inc. (NASDAQ: ECYT) is trading like the company is being acquired. This is proof that any biotech with great cancer drug news can run, regardless of market conditions. It ...
Read Full Story »
110928049

Ten Huge Companies Dodged State Taxes for Five Years

States, often burdened by budget deficits that grew during the recession, are not getting tax receipts from some of America's largest companies. Among them are Boeing Co. (NYSE: BA) and ...
Read Full Story »
percent sign button

Short Interest Generally Wanes in High-Yield Dividend Stocks

The short interest data for the final two weeks of February is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. ...
Read Full Story »
Citigroup logo

Low P/E High-Dividend Blue Chip Leaders to Buy Now

The pricier the stock market gets, the more important it is for investors to keep a close eye on what they are paying for stocks. When the market moved up ...
Read Full Story »
Pills

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Wall Street firms are famous for their ability to throw conference after conference, year after year. Some are highly respected, and a must-attend for investment firms and portfolio managers. Others ...
Read Full Story »
biotech

Biotech Buyout Bolsters Novartis Cancer Portfolio

Pharmaceutical giant Novartis A.G. (NYSE: NVS) announced Monday morning that it will acquire startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer ...
Read Full Story »